M. Suliman

发表

EFFECT OF ORAL N-ACETYLCYSTEINE TREATMENT ON PLASMA INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PERITONEAL DIALYSIS PATIENTS: A PLACEBO-CONTROLLED STUDY

B. Lindholm, M. Riella, M. M. Nascimento, 2010, Peritoneal Dialysis International.

THE USE OF SUGARCANE BAGASSE ASH AS AN ALTERNATIVE LOCAL POZZOLANIC MATERIAL: STUDY OF CHEMICAL COMPOSITION

M. Suliman, Samah M. Fudl Almola, 2011 .

Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.

J. Carrero, P. Stenvinkel, B. Lindholm, 2008, Clinical nutrition.

Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.

P. Stenvinkel, B. Lindholm, J. Bergström, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.

R. Manfro, P. Stenvinkel, A. Bruchfeld, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.

P. Stenvinkel, B. Lindholm, M. Suliman, 2008, Advances in clinical chemistry.

A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.

P. Stenvinkel, M. Schalling, R. Pecoits-Filho, 2003, Kidney international. Supplement.

Bone Mineral Density in End-Stage Renal Disease Patients: Association with Wasting, Cardiovascular Disease and Mortality

P. Stenvinkel, B. Lindholm, J. Axelsson, 2008, Blood Purification.

Associations between the CYBA 242C/T and the MPO –463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients

P. Stenvinkel, Sawako Kato, R. Pecoits-Filho, 2007, Blood Purification.

Risk Factors for Cardiovascular Disease in Patients Undergoing Peritoneal Dialysis

J. Carrero, P. Stenvinkel, B. Lindholm, 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

R. Vanholder, P. Stenvinkel, B. Lindholm, 2007, Clinica chimica acta; international journal of clinical chemistry.

The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration – The Pan Thames Renal Audit

J. Carrero, P. Stenvinkel, M. Schalling, 2010 .

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

J. Carrero, P. Stenvinkel, M. Schalling, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Associations between circulating inflammatory markers and residual renal function in CRF patients.

P. Stenvinkel, R. Pecoits-Filho, B. Lindholm, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Modification of the oxidative stress biomarker AOPP assay: application in uremic samples.

P. Stenvinkel, B. Lindholm, M. Suliman, 2008, Clinica chimica acta; international journal of clinical chemistry.

Low serum fetuin‐A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients

J. Carrero, P. Stenvinkel, B. Lindholm, 2008, European journal of clinical investigation.

Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.

P. Stenvinkel, B. Lindholm, P. Bárány, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hyperhomocysteinemia in Chronic Renal Failure Patients: Relation to Nutritional Status and Cardiovascular Disease

B. Lindholm, J. Bergström, P. Bárány, 2001, Clinical chemistry and laboratory medicine.

Predictors of Carotid Artery Intima-Media Thickness in Chronic Kidney Disease and Kidney Transplant Patients without Overt Cardiovascular Disease

J. Carrero, J. Axelsson, A. Qureshi, 2009, American Journal of Nephrology.

Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients.

B. Lindholm, J. Bergström, P. Bárány, 1999, Journal of the American Society of Nephrology : JASN.

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.

J. Carrero, P. Stenvinkel, M. Schalling, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

J. Carrero, P. Stenvinkel, B. Lindholm, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.

P. Stenvinkel, B. Lindholm, A. Qureshi, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Eculizumab as treatment in dense deposit disease in children

M. Suliman, Saeed M Alzabli, Abdulkarim Al anazi, 2018 .

Total, free, and protein-bound sulphur amino acids in uraemic patients.

B. Lindholm, J. Bergström, M. Suliman, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients.

J. Bergström, M. Suliman, B. Anderstam, 1996, Kidney international.

The release of leptin and its effect on hormone release from human pituitary adenomas

M. Korbonits, A. Grossman, J. Burrin, 2001, Clinical endocrinology.

[Association between body fat, inflammation and oxidative stress in hemodialysis].

R. Manfro, B. Lindholm, M. Riella, 2010, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?

S. Czene, M. Harms-Ringdahl, S. Haghdoost, 2006, Antioxidants & redox signaling.

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.

J. Carrero, P. Stenvinkel, G. Garibotto, 2008, Clinica chimica acta; international journal of clinical chemistry.

Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.

P. Stenvinkel, B. Lindholm, J. Axelsson, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study.

P. Stenvinkel, B. Lindholm, M. Riella, 2006, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.

J. Carrero, P. Stenvinkel, B. Lindholm, 2009, Journal of nephrology.

Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients.

B. Lindholm, J. Bergström, P. Bárány, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The kidney is the major site of S-adenosylhomocysteine disposal in humans.

G. Garibotto, M. Balbi, B. Lindholm, 2009, Kidney international.

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.

J. Carrero, P. Stenvinkel, B. Lindholm, 2007, Clinical journal of the American Society of Nephrology : CJASN.

IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas.

J. Royds, W. Timperley, L. Baxter, 1999, European journal of endocrinology.

Telomere length and telomere repeat-binding protein in children with sickle cell disease

N. Al-Daghri, M. Suliman, M. Ansari, 2021, Pediatric Research.

Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality.

P. Stenvinkel, B. Lindholm, J. Axelsson, 2007, The American journal of clinical nutrition.

Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality.

P. Stenvinkel, B. Lindholm, A. Qureshi, 2008, The American journal of clinical nutrition.

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease

P. Stenvinkel, B. Lindholm, J. Axelsson, 2007, Journal of internal medicine.

Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease.

P. Stenvinkel, B. Lindholm, A. Qureshi, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.

P. Stenvinkel, B. Lindholm, A. Qureshi, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Accumulation of taurine in patients with renal failure.

B. Lindholm, J. Bergström, P. Bárány, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Interleukin-6 Is a Better Predictor of Mortality as Compared to C-Reactive Protein, Homocysteine, Pentosidine and Advanced Oxidation Protein Products in Hemodialysis Patients

R. Manfro, P. Stenvinkel, B. Lindholm, 2008, Blood Purification.

Long-term treatment of acromegaly with the somatostatin analogue SR-lanreotide

R. Battersby, T. Powell, M. Suliman, 1999, Journal of endocrinological investigation.

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients

P. Stenvinkel, B. Lindholm, A. Qureshi, 2023, Frontiers in Nutrition.

CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Homocysteine‐Lowering Is Not a Primary Target for Cardiovascular Disease Prevention in Chronic Kidney Disease Patients

P. Stenvinkel, B. Lindholm, A. Qureshi, 2007, Seminars in dialysis.

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.

K. Kalantar-Zadeh, E. Vonesh, P. Stenvinkel, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.

P. Stenvinkel, B. Lindholm, P. Bárány, 2006, Seminars in nephrology.

Homocysteine in uraemia--a puzzling and conflicting story.

K. Kalantar-Zadeh, P. Stenvinkel, B. Lindholm, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Contribution of inflammation to vascular disease in chronic kidney disease patients.

P. Stenvinkel, M. Suliman, 2008, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

J-shaped mortality relationship for uric acid in CKD.

J. Carrero, P. Stenvinkel, B. Lindholm, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The 12th International Conference on Continuous Renal Replacement Therapies (CRRT). March 7–10, 2007, San Diego, Calif.

S. Heffelfinger, P. Stenvinkel, Sawako Kato, 2007, Blood Purification.

Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.

B. Sjöberg, M. Suliman, B. Anderstam, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease?

T. Ekström, P. Stenvinkel, M. Schalling, 2007, Journal of internal medicine.

CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Homocysteine‐Lowering Is Not a Primary Target for Cardiovascular Disease Prevention in Chronic Kidney Disease Patients

P. Stenvinkel, B. Lindholm, A. Qureshi, 2007, Seminars in dialysis.

Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.

P. Stenvinkel, B. Lindholm, P. Bárány, 2006, Seminars in nephrology.

Associations between the CYBA 242C/T and the MPO –463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients

P. Stenvinkel, Sawako Kato, R. Pecoits-Filho, 2007, Blood Purification.

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients

P. Stenvinkel, B. Lindholm, A. Qureshi, 2023, American Journal of Nephrology.

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.

Mohamed, P. Stenvinkel, B. Lindholm, 2000, Kidney international.